Introduction
Tumor necrosis factor alpha (TNFa) is a multifunctional cytokine that is produced by activated macrophages as well as by several other cell types, including activated lymphocytes, fibroblasts, and hepatocytes. TNFa is also produced by a large variety of tumor cells of both nonhematopoietic and hematopoietic origin. As a matter of fact, overexpression of TNFa has been implicated in a number of pathological conditions related to chronic inflammation, cancer, and aging. Although TNFa may exert multiple biological effects depending on the cellular origin, it has been extensively described that TNFa is a potent cytostatic or cytotoxic agent in many transformed and normal cells. For example, TNFa is considered as one of the most important negative regulators of steady-state normal hematopoiesis. Indeed, TNFa decreases cytokine-driven hematopoietic stem cell (HSC) expansion, interferes with HSC self-renewal, and compromises the ability of HSC to reconstitute hematopoiesis Dybedal et al., 2001) . Moreover, TNFa acts on the more mature hematopoietic cell compartment by inhibiting the development of committed myeloid progenitors (Murase et al., 1987) , and interfering with both erythroid and megacaryocyte precursor terminal differentiation (De Maria et al., 1999) . Consistent with these findings, TNFa overproduction has been implicated in hematopoietic failure related to diverse pathological situations, such as severe infections, cancers, and hematopoetic disorders, including myelodysplasia (MDS) (Kitagawa et al., 1997) , acute myeloid leukemia (AML) (Oster et al., 1989) , and aplastic anemia (Young, 2000) .
At the cellular level, the mechanism by which TNFa influences hematopoiesis is not totally understood. Indeed, in most hematopoietic cellular models, such as U937, HL-60, OCI-AML-1, or OCI-AML-11 leukemic cell lines, TNFa induces rapid interphasic apoptotic cell death (Quentmeier et al., 2000) . However, in other leukemic cellular models, TNFa has been found to induce cell growth inhibition without affecting cell viability (Tobler et al., 1987) . Moreover, prolonged cell growth inhibition has been also described in TNFatreated tumor epithelial cells (Jeoung et al., 1995) . In the latter study, it has been proposed that TNFa inhibitory effect was related to the induction of p21 , a potent inhibitor of cyclin-dependent kinases (Jeoung et al., 1995) . From these studies, it appears that apoptosis may not be the unique mechanism by which TNFa regulates hematopoietic cell expansion. As a matter of fact, we have already reported that TNFa did not induce apoptosis in several leukemic cells, including KG1 cells, and that these cells were also resistant to apoptosis induced by Fas and genotoxic agents, suggesting a severe intrinsic defect in the apoptotic machinery (Quillet-Mary et al., 1996) .
In a recent study, it has been described that, in human diploid fibroblasts, treatment with TNFa resulted in irreversible growth arrest, telomere shortening, and increased acid b-galactosidase (b-gal) activity, suggesting that TNFa may also trigger premature senescence in these cells (Dumont et al., 2000) . The ability of TNFa to induce senescence in hematopoietic cells has never been reported. The present study was aimed to investigate whether TNFa could induce senescence in KG1 cells used as a model of resistance to TNFa-induced apoptosis, and, if this is the case, to determine the functional consequences in term of genetic instability.
Results

TNFa induces a senescence state in KG1 cells
KG1 cells were treated with TNFa (20 ng/ml) for 15 days and cell viability was measured by using trypan blue assay. Untreated cells, which displayed a doubling time of 42 h, were diluted with fresh medium every 2-3 days over 15 days. As shown in Figure 1 , in the presence of TNFa, cell proliferation was initially unaffected during 24 h, then decreased over an additional period of 3 days, after which TNFa-treated cells displayed complete growth arrest over a 2-week period.
Flow cytometry analysis revealed no major changes in KG1 immunophenotype (CD34 þ CD38 þ CD33 þ ), except a slight reduction of CD34 expression level after 15-days culture (data not shown).
Cell cycle analysis after PI staining revealed progressive increase in subG1 cells, no major changes in G1 phase but significant reduction of phase S and G2-M cell fraction (Table 1) . Annexin V-binding analysis showed that, whereas treatment with TNFa (20 ng/ml) for 72 h resulted in apoptosis in U937 cells (15.7% of annexin Vpositive cells), KG1 cells were resistant (3.5% of annexin V-positive cells after 15 days) (data not shown). Similar results were obtained with higher TNFa doses (50 ng/ ml) or longer exposure (7 or 15 days) (data not shown). The lack of apoptosis was also evidenced by DAPI staining after a different time exposure (data not shown).
TNFa induced a time-dependent decrease in DNA synthesis, as assessed by both thymidine incorporation and BrdU/PI double-staining. Thymidine incorporation decrease became detectable after 3 days and reached a maximum of 68% reduction after 15 days (for a representative experiment, see Figure 2a ). This result is in agreement with the labeling index calculated after anti-BrdU staining (Figure 2b ).
Morphological analysis after MGG staining revealed that TNFa-treated KG1 cells displayed no major changes, except that cells presented enlarged vacuoles and became granular. However, cytochemical studies showed a time-dependent increase in the percentage of cells positive for senescence-associated b-galactosidase activity (SA-b-gal) (Figure 3a and b) .
The fact that TNFa-treated cells displayed no features of apoptosis but seemed permanently arrested, displayed reduced DNA synthesis, and acquired high SA-b-gal activity, and was consistent with a senescence state. Previous studies have shown that the induction of cellular senescence correlates with the activation of p21 WAF-1 gene through either p53-dependent or independent pathways. Since KG1 displayed a mutant form of p53 (Sugimoto et al., 1992) , we directly investigated the effects of TNFa on p21 WAF-1 protein expression. As a matter of fact, TNFa induced an increase in p21 expression which was detectable as soon as 4 h (data not shown) with a maximum at 24 h, after which p21 WAF-1 expression decreased and became undetectable after 6 days ( Figure 4) .
Altogether, these results suggest that TNFa induced a senescence state in KG1 cells.
TNFa reduces hTERT activity and gene expression in KG1 cells
Previous studies have documented that hTERT, the catalytic component of human telomerase, protects cells (Yang et al., 1999; Zhu et al., 1999) . For this reason, we investigated whether prolonged exposure to TNFa could influence hTERT gene expression and activity. As shown in Figure 5a , TNFa induced a time-dependent hTERT activity decrease. Moreover, TNFa induced a reduction in hTERT gene expression as revealed by both semiquantitative RT-PCR and real-time PCR. As shown in Figure 5b and c, hTERT transcripts rapidly decreased (within 2 h), and then remained stable over 14 days (see below).
TNFa induces senescence markers in fresh AML cells and human CD34 þ progenitors
Whether TNFa could induce senescence markers in leukemic cells derived from patients with AML was also investigated. In these experiments, fresh AML cells were incubated in liquid culture enriched by CM-5637 conditioned medium with or without TNFa (20 ng/ml) for 7 days and processed for SA-b-gal activity. As shown in Table 2 , in the seven samples tested, treatment with TNFa resulted in an increase in SA-b-gal-expressing cells in four out of seven cases. We also investigated whether TNFa could induce senescence markers in human CD34 þ progenitors isolated from normal bone marrow and cultured in liquid culture in the presence of appropriate cytokines (see Materials and methods). As shown in Table 3 , treatment with TNFa for 14 days resulted in an increased fraction of SA-b-gal-expressing cells in the three samples tested.
TNFa induces chromosomal abnormalities in KG1 cells
Previous studies have established that cellular senescence correlates with chromosome alterations, including telomere shortening, dicentric chromosome due to direct end-to-end fusion, and karyotype abnormalities (for a review, see Mathieu et al., 2004) . First, we investigated the influence of TNFa on telomere length in KG1 cells by using the flow-FISH technique. As shown in Figure 6a , treatment with TNFa resulted in a significant reduction in telomere length with a maximum at 15 days. The TNFa-induced telomere shortening was confirmed by PNA-telomere FISH on metaphases (data not shown). All chromosomes were affected by telomere shortening ( Figure 6b ). Moreover, telomere losses increased drastically after 15-days TNFa treatment.
The percentage of metaphases with at least one telomere loss increased from 9 (control) to 44% (treated). Moreover, the rate of telomere losses per metaphases is five times higher in treated cells (data not shown). Second, end-to-end fusions involving shortened (see junctions 2-8 and 7-8) telomeric sequences or unshortened (see junctions 5-10 and 6-13) telomeric sequences were detected in 15-days TNFa-treated KG1 cells ( Figure 6c ).
Third, we found that treatment with TNFa resulted in major changes in KG1 karyotype, as revealed by Rbanding cytogenetic analysis. In six independent analyses, we found that, whereas KG1 cells displayed complex chromosome abnormalities, the cytogenetic profile was remarkably stable (Table 4) . However, treatment with TNFa resulted in additional cytogenetic abnormalities such as partial monosomy 2p, loss of one i(8)(q10), trisomy or tetrasomy 11q (Table 4) . These data were confirmed by M-FISH analysis, indicating that chromosomes 2, 8, and 11 are very frequently involved in additional cytogenetic abnormalities including telomeric fusions and deletion. The overinvolvement of these specific chromosomes was also detected in control cells, indicating that TNFa increased a preexisting chromosome instability.
GM-CSF counteracts the effects of TNFa in KG1 cells
In further experiments, we considered the possibility that GM-CSF could counteract the effects of TNFa.
In the first set of experiments, KG1 cells were cotreated with TNFa (20 ng/ml) and GM-CSF (13 ng/ml), and cell proliferation, percentage of b-gal-positive cells, telomere attrition, and hTERT activity were measured. As shown in Figure 7 , we found that GM-CSF partially inhibited the effect of TNFa on cell proliferation (Figure 7a ), SA-b-gal distribution (Figure 7b ), telomere In the second set of experiments, we also investigated whether GM-CSF was capable of rescuing KG1 cells after prolonged exposure to TNFa. In these experiments, cells were treated with TNFa for 15 days, washed, then treated or not with GM-CSF for an additional period of 2 weeks. After withdrawal of TNFa, KG1 cells did not recover proliferation up to an additional period of 2 weeks (Figure 8 ). However, when these cells were cultured in the presence of GM-CSF, they recovered proliferation over a 2-week period (Figure 8 ) although growth kinetics remained lower than that of untreated cells. Moreover, upon GM-CSF stimulation, telomerase activity and telomere length increased, compared to untreated cells (results not shown). Interestingly, whereas treatment with TNFa for 2 weeks resulted in additional chromosomal changes in a fraction of cell population (see Table 4 ), cells rescued by GM-CSF displayed cytogenetic profiles identical to those of the KG1 stem line (data not shown).
Altogether, these results suggest that not only does GM-CSF prevent TNFa-induced senescence, but also does it allow cells to escape from senescence. However, these results suggest also that rescued cells derived from the cell fraction, which escape to the pathogenic effect of TNFa on chromosomes.
Discussion
The present study describes that, in KG1 cells, TNFa induced no apoptosis but a senescence state characterized by prolonged growth arrest, increase in b-gal activity, telomere loss, and chromosomal abnormalities. The mechanism by which TNFa induced a senescent state in KG1 cells was not directly investigated and remains therefore incompletely elucidated. However, we found that TNFa inhibits hTERT gene expression not only in KG1 cells, but also in all AML cell samples tested. Moreover, we found a temporal relationship between senescence and inhibition of hTERT gene expression and activity. This finding supports the hypothesis that TNFa acts at hTERT level. If this is the case, the mechanism by which TNFa interferes with hTERT gene regulation should be examined. In this perspective, it should be pointed out that, in some, but not all, AML cells, TNFa induced ceramide production , a potent lipid second messenger, which has been shown to regulate hTERT gene in other cellular models (Ogretmen et al., 2001a, b) . Such hypothesis could explain the protective effect of GM-CSF since this cytokine has been shown to interfere with ceramide metabolism (Kelly et al., 1998) . Alternatively, it is also possible that TNFa operates through a hTERT-independent mechanism. The fact that telomerase activity remained as high as 80% of the control at day 7 when SA-b-gal activity increased supports this hypothesis. The role of hTERT in regulating stressinduced senescence has been recently questioned (Gorbunova et al., 2002) . Moreover, it has been recently described that, whereas genotoxic or oxidative insults may result in telomere loss, the latter does not necessarily involve telomerase dysfunction but rather implies telomere disturbance due to the accumulation of DNA damage in telomeric or subtelomeric regions (von Zglinicki, 2002) . These findings could have important implications in the context of our study. Indeed, previous studies have documented that TNFa triggers the production of radical oxygen species (ROS) from different sources, induced the formation of 8-hydroxy-2 0 -deoxyguanosine (8oxG) DNA oxidative lesions (Park et al., 1998) as well as the formation of DNA breaks (Baloch et al., 1990; Nathan et al., 2000) . Therefore, it remains quite conceivable that TNFa induced senescence by disrupting telomere structure through ROS production independently of hTERT negative regulation. Of course, it is also possible that TNFa activates both telomerase-dependent and telomerase-independent mechanisms, which act in concert through telomere disturbance due to direct DNA damage and impaired telomere maintenance due to decreased telomerase activity. Fresh leukemic cells were treated or not with TNFa (20 ng/ml) for 7 days and stained for SA-b-gal activity. Results are expressed as percentage of SA-b-gal-positive cells Our study shows that senescent KG1 cells displayed chromosomal instability characterized by end-to-end fusions, gain or loss of genetic materials. The latter finding is not surprising, based on previous studies which have demonstrated that senescence state correlates with genetic instability, perhaps due to illegitimate DNA recombination (for a review, see Maser and DePinho, 2002) . However, the fact that TNFa could induce genetic instability in myeloid cells has never been reported. There is little doubt that these gross chromosomal abnormalities contribute to cell growth inhibition and cellular loss (for a review, see Mathieu et al., 2004) . Therefore, it could be possible that, in vivo, chromosome damaging represents one of the mechanisms by which TNFa operates as a negative regulator of normal hematopoiesis, particularly in cells inherently resistant to apoptosis. This hypothesis should be investigated in liquid culture of hematopoietic stem cells driven to specific lineage upon stimulation by appropriate cytokines. These experiments are currently performed in our laboratory.
Our study shows that GM-CSF, the principle stimulator of myeloid lineage, at least partially inhibits TNFa-induced senescence in KG1 cells. The fact that GM-CSF, in parallel, counteracted the inhibitory effect of TNFa on hTERT gene expression and prevented telomere shortening and senescence strengthens the role of hTERT inhibition in TNFa-induced senescence. GM-CSF could not be the unique growth factor involved in hTERT regulation in hematopoietic cells. Indeed, it has been recently reported that IGF-1 or IL6 abrogated dexamethasone-induced downregulation of hTERT mRNA in multiple myeloma cells through PI3K and NF-kB pathways (Akiyama et al., 2002) . Altogether, these results support the notion that, at least in hematopoietic cells, growth factors may confer a significant protection against stress-induced senescence by interfering with hTERT gene regulation. Our study also shows that GM-CSF stimulation allows cells to escape from TNFa-induced senescence. However, we found that GM-CSF stimulation results in the expansion of cells, which display basal cytogenetic profile. Thus, GM-CSF stimulation was unable to perpetuate the chromosome abnormalities acquired during the senescence phase. Moreover, this result suggests that the cellular fraction, which harbors additional chromosomal changes upon treatment with TNFa, will ultimately die, unless other molecular events occur.
Our study may have important clinical implications in the context of pathological situation associated with TNFa overproduction. Indeed, based on our study, one can speculate that, in these conditions, at least a subset of immature hematopoietic cells could enter into senescence with two important functional consequences: first, limitation of hematopoietic cell expansion; second, and perhaps more importantly, genetic instability.
Moreover, it is also conceivable that TNFa induces telomere disturbances and subsequent genetic instability in other tissues. This could establish a link between chronic inflammation and carcinogenesis as suggested in ulcerative colitis, which associates TNFa overproduction, telomere attrition, and chromosomal instability (O'Sullivan et al., 2002; Tsukada et al., 2002) .
To conclude, this study shows for the first time that, at least in some hematopoietic cells, TNFa may induce senescence with important functional consequences, including sustained growth inhibition and genetic instability, and that this cellular response is efficiently regulated by hematopoietic growth factors.
Materials and methods
Cell culture and treatment KG1 myeloblastic cell line was purchased from ATCC (CCL-246) (Rockville, MD, USA) and cultured in IMDM medium (Invitrogen corporation, Gibco, Cergy Pontoise, France) supplemented with 20% heat-inactivated fetal bovine serum (FBS), 100 U/ml penicillin, and 100 mg/ml streptomycin and kept at 371C in a humidified atmosphere containing 5% CO 2 . The cell concentration was maintained at 4 Â 10 5 cells/ml by diluting the cells with fresh medium every 2-3 days. Human recombinant TNFa (PeproTech-TEBU, Rocky Hill, NJ, USA) and human recombinant granulocyte-macrophage colonystimulating factor (GM-CSF) (R&D Systems, Oxon, UK) were used at 20 ng/ml and at 13 ng/ml, respectively, and added to fresh medium every 2 days. Cell viability was assessed by trypan blue exclusion. 46,XY,der(4)t(4;8)(q31;?q23),À5,del(7)(q21;q35), der(8)t(8;12)(p12;q13),+i(8)(q10)x2, À12, add(17)(p12), der (20) 46,XY,der(4)t(4;8)(q31;?q23),À5,del(7)(q21;q35), der(8)t(8;12)(p12;q13),+i(8)(q10)x2, À12, add(17)(p12), der (20) 46,XY,der(4)t(4;8)(q31;?q23),À5,del(7)(q21;q35), der(8)t(8;12)(p12;q13),+i(8)(q10)x2, À12, add(17)(p12), der (20) Fresh leukemic cells were obtained from unselected AML patients at diagnosis after informed consent and defined according to the French American British (FAB) classification. Bone marrow aspirates were collected in heparinized syringes and mononuclear cells were separated by centrifugation through a Ficoll-Hypaque density gradient. Cells were washed twice in IMDM, resuspended at a final concentration of 2 Â 10 7 cells/ml and cryopreserved in IMDM containing 10% dimethylsulfoxide and 50% FBS or immediately processed for assays. After processing (Ficoll preparation, freezing and thawing), the percentage of leukemic cells was higher than 90% in all cases. Leukemic cells were cultured in IMDM containing 10% CM-5637 conditioned medium (5637 is a bladder carcinoma cell line).
Normal bone marrow progenitors were obtained from discarded fragments undergoing hip surgery on hematological healthy patients after informed consent. In brief, mononuclear cells were obtained from bone marrow by Ficoll-Hypaque density gradient centrifugation, after which isolation of progenitors was performed by positive selection of CD34-expressing cells using MACS CD34 Microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany) . The purity of the CD34 þ cells was evaluated by flow cytometry using CD45 and CD34 monoclonal antibodies and reached 85-98%. Human progenitor cells were cultured in IMDM containing 10% FBS supplemented with 100 ng/ml stem cell factor, 1 U/ ml interleukin 3, 100 ng/ml fms-like tyrosine kinase type 3 ligand (FLT3-L), and 5 pg/ml thrombopoietin. 
Cell cycle analysis
5 Â 10 5 cells were centrifugated for 10 min at 1000 r.p.m. at 41C, fixed in PBS with 70% ethanol overnight at 41C, then centrifugated at 3000 r.p.m. for 5 min, and incubated at least 30 min at room temperature with propidium iodide (50 mg/ml) and RNase (0.1 mg/ml). Sample analysis was performed with an EPICS XL-MCL (Beckman Coulter, Villepinte, France).
Proliferation assay and apoptosis detection
Detection of BrdU incorporation in DNA-synthesizing cells was performed by flow cytometry using FITC-conjugated mouse monoclonal anti-BrdU antibody (BD Biosciences, San Diego, CA, USA). Detection of [ 3 H]thymidine (0.5 mCi/ml) (Amersham, les Ullis, France) incorporation was performed by scintillation counting.
Annexin V-FITC kit (Immunotech, Coulter Company, Marseille, France) was used according to the manufacturer's recommendations for apoptosis detection.
Changes in cellular chromatin were evaluated by fluorescence microscopy by DAPI (4 0 ,6 0 -diamino 2-phenylindol) staining as described previously .
Senescence-associated b-gal staining SA-b-gal staining was performed as described previously (Dimri et al., 1995) . Briefly, cells were cytocentrifuged, washed in PBS/pH 6, fixed with 2% formaldehyde/0.2% glutaraldehyde for 15 min at 41C, and then washed in PBS at room temperature. Cells were incubated with fresh SA-b-gal staining solution (1 mg of 5-bromo-4-chloro-3-indolyl b-D-galactoside (X-gal) per ml, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 40 mM sodium phosphate/pH 6, 150 mM NaCl, 2 mM MgCl 2 ) and incubated at 371C for 14-16 h. The slides were washed and then counterstained for 3 min with hematoxylin. Positive cells were counted by two independent investigators under bright field at Â 100 magnification.
Telomere length analysis
The average length of telomere repeats at chromosome ends in KG1 cells was measured by flow-FISH using a telomere PNA kit (Dako, Trappes, France) as recommended by the manufacturer. Briefly, KG1 cells and 1301 cells (T-cell lymphoblastic leukemia used as control cells) were incubated overnight at room temperature in the dark with a fluorescein-labeled peptide nucleic acide (CCCTAA) 3 probe. After hybridization, cells were washed and DNA staining was performed, after which samples were analysed on a flow cytometer (FACS Calibur, Becton Dickinson Immunocytometry Systems, San Jose, CA, USA) using logarithmic scale FL1-H for probe fluorescence and linear scale FL3-H for DNA staining. The mean fluorescence intensity was evaluated for both KG1 cells and 1301 control cells. The relative telomere length (RTL) was calculated as the ratio between these two values. All samples were run in duplicate determination.
Telomerase activity analysis
Quantitative determination of telomerase activity was performed using the Telomeric Repeat Amplification Protocol (TRAP) with teloTAGGG telomerase PCR ELISA PLUS kit (Roche Diagnostics, Mannheim, Germany) following the manufacturer's instructions.
Briefly, 2 Â 10 5 cells were lysed and centrifuged. In all, 2 ml of cell extract was added to Master mix. Sample telomerase added telomeric repeats to the 3 0 -end of the biotin-labeled synthetic primers. These elongation products, as well as internal standard, were amplified by PCR. The amount of hexamers added by the telomerase contained in each sample was then evaluated by the ELISA technique using TTAGGGspecific probes. The relative telomerase activity (RTA) was determined, that is, absorbance of the sample compared to absorbance of the control template.
RT-PCR and RQ-PCR
Total RNA was isolated by Trizol Reagent (Invitrogen, Cergy Pontoise, France).
Semiquantitative RT-PCR was performed using 800 ng of total RNA, amplified in a Biometra thermal cycler using oligonucleotides (2 mM of each) 5 0 TGA ACT TGC GGA AGA CAG TGG 3 0 and 5 0 ATG CGT GAA ACC TGT ACG CCT 3 0 in a 50 ml reaction volume using Ready-To-Got RT-PCR beads (Amersham Pharmacia Biotech). b-Actin mRNA levels were used for the normalization of RNA. After reverse transcription at 421C for 20 min, followed by 5 min at 951C, 25 amplification cycles were carried out (941C for 30 s, 601C for 45 s, 721C for 1 min). The amplification products were electrophoresed in 2% agarose gels and products of RT-PCR were visualized with UV detection (hTERT 351 bp; b-actin 641 bp).
Quantitative RT-PCR was performed using LightCycler TeloTAGGGhTERT quantification kit (Roche Diagnostics, Mannheim, Germany) as indicated by the manufacturer. Briefly, hTERT mRNA was reverse transcribed and amplified with specific primers in a one-step RT-PCR reaction. The amplicon was detected by fluorescence, using a specific pair of probes that hydridize to an internal sequence of the amplified fragment during the annealing phase of the amplification cycle. The emitted fluorescence was measured by the LightCycler instrument. In a separate one-step RT-PCR, mRNA encoding for porphobilinogen deaminase (PBGD) was processed for use as house-keeping gene. Results were expressed as the ratio between hTERT and PBGD transcripts.
Western blot
Cells were harvested and lysed with Laemli buffer, sonicated, and boiled at 5 min at 951C. Samples were separated on 12.5% SDS-PAGE gels, transferred onto nitrocellulose membrane, and immunostained. The following primary antibodies were used: anti-p21, anti-actin (Santa Cruz, Le Perray en Yvelines, France) and horseradish peroxidase-labeled anti-mouse antibodies. Proteins were visualized using the ECL detection system (Pierce, Rockford, IL, USA).
Cytogenetic analyses
Cell metaphases were harvested and treated according to the standard procedure. Chromosomes were identified with the RHG-banding technique and karyotypes were described according to the ISCN 1995 nomenclature. Telomeres are detected by (C 3 TA 2 ) 3 PNA-Cy 3 probe (Perceptive Biosystem). Hybridization and detection of specific whole chromosome painting multi-FISH probes (MetaSystems, GmbH) were performed according to the manufacturer's recommendations. Hybridized metaphases were captured with a CCD camera (Zeiss) coupled to a Zeiss Axioplan microscope and were processed with the ISIS software (MetaSystems, GmbH).
Statistics
Results are expressed as mean values. Statistical significance of the data was analysed by the Student's t-test.
